From: 99mTc-labelled PSMA ligand for radio-guided surgery in nodal metastatic prostate cancer: proof of principle
Sensitivity %
Specificity %
PPV %
NPV %
n = 406 samples
76.6 (118/154)
CI (0.69–0.83)
94.4 (238/252)
CI (0.91–0.97)
89.4 (118/132)
CI (0.83–0.94)
86.9 (238/274)
CI (0.82–0.91)
n = 154 samples with tumor
n = 252 samples free of cancer